# Vaccine and Treatment Evaluation Units: Phase IV Clinical Trial in Adults with Community Acquired Pneumonia to Assess the Effect of Early Empiric Antifungal Treatment of Coccidioidomycosis Pneumonia

> **NIH NIH N01** · DUKE UNIVERSITY · 2024 · $93,126

## Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

## Key facts

- **NIH application ID:** 11177564
- **Project number:** 272201300017I-P00009-27200008-1
- **Recipient organization:** DUKE UNIVERSITY
- **Principal Investigator:** SUSANNA NAGGIE
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $93,126
- **Award type:** —
- **Project period:** 2015-06-10 → 2024-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11177564

## Citation

> US National Institutes of Health, RePORTER application 11177564, Vaccine and Treatment Evaluation Units: Phase IV Clinical Trial in Adults with Community Acquired Pneumonia to Assess the Effect of Early Empiric Antifungal Treatment of Coccidioidomycosis Pneumonia (272201300017I-P00009-27200008-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/11177564. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*